Fanciulli Gabriele, Favara Giuliana, Maugeri Andrea, Barchitta Martina, Agodi Antonella, Basile Guido
Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.
Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, Catania, Italy.
World J Emerg Surg. 2025 Jun 7;20(1):50. doi: 10.1186/s13017-025-00622-6.
Acute cholecystitis (AC) is a common and serious condition characterized by gallbladder inflammation, most often caused by cystic duct obstruction due to gallstones. Although laparoscopic cholecystectomy (CC) is the preferred surgical treatment, percutaneous cholecystostomy (PC) is frequently considered for high-risk surgical patients. The optimal management strategy for these patients remains a topic of debate. These systematic review and meta-analysis aim to provide an updated evaluation of studies comparing the clinical outcomes of AC patients treated with PC versus those undergoing CC, as well as the outcomes of CC alone versus PC followed by CC.
A literature search was carried out across Web of Science, Medline, Embase, and PubMed up to April 2024. Observational studies comparing patients undergoing PC versus CC, as well as CC versus PC followed by CC, and reporting mortality, morbidity, and readmission were included. Data extraction and quality assessment were independently performed by two reviewers, with bias risk evaluated using the Newcastle-Ottawa Quality Scale. The pooled odds ratio (OR) was obtained through meta-analyses by using STATA software (Version 18).
A total of 27 studies were included, with 16 comparing PC versus CC and 11 assessing PC followed by CC versus CC alone. Meta-analyses revealed that CC was associated with significantly lower mortality (OR = 0.26; 95% CI = 0.14-0.48) and readmission rates (OR = 0.37; 95% CI = 0.18-0.75) compared to PC. The benefits of laparoscopic cholecystectomy over percutaneous cholecystostomy were particularly evident for mortality (OR = 0.17; 95% CI = 0.09-0.33), while a non-significant trend towards reduced readmission rates was also observed (OR = 0.28; 95% CI = 0.07-1.13). However, PC was identified as a viable alternative in high-risk surgical patients. Studies examining PC followed by CC versus CC alone showed diverse results, with some indicating reduced surgical complications and improved outcomes, while others reported no significant benefits.
This work highlights that CC is associated with better outcomes, including lower mortality and readmission rates, compared to both PC alone and PC followed by CC. The combined approach did not show a significant advantage over immediate CC. Further research with larger studies and standardized protocols is needed to refine treatment strategies for high-risk AC patients.
急性胆囊炎(AC)是一种常见且严重的疾病,其特征为胆囊炎症,最常见的病因是胆结石导致的胆囊管梗阻。尽管腹腔镜胆囊切除术(CC)是首选的手术治疗方法,但对于高风险手术患者,经皮胆囊造瘘术(PC)也经常被考虑。这些患者的最佳管理策略仍是一个有争议的话题。本系统评价和荟萃分析旨在对比较接受PC治疗的AC患者与接受CC治疗的患者的临床结局,以及单独CC与PC后再行CC的结局的研究进行更新评估。
截至2024年4月,在科学网、Medline、Embase和PubMed上进行了文献检索。纳入比较接受PC与CC治疗的患者,以及CC与PC后再行CC治疗的患者,并报告死亡率、发病率和再入院率的观察性研究。由两名 reviewers 独立进行数据提取和质量评估,使用纽卡斯尔 - 渥太华质量量表评估偏倚风险。通过使用STATA软件(版本18)进行荟萃分析获得合并比值比(OR)。
共纳入27项研究,其中16项比较PC与CC,11项评估PC后再行CC与单独CC。荟萃分析显示,与PC相比,CC的死亡率(OR = 0.26;95% CI = 0.14 - 0.48)和再入院率(OR = 0.37;95% CI = 0.18 - 0.75)显著更低。腹腔镜胆囊切除术相对于经皮胆囊造瘘术在降低死亡率方面的益处尤为明显(OR = 0.17;95% CI = 0.09 - 0.33),同时也观察到再入院率有降低的非显著趋势(OR = 0.28;95% CI = 0.07 - 1.13)。然而,PC被认为是高风险手术患者的一种可行替代方案。比较PC后再行CC与单独CC的研究结果各异,一些研究表明手术并发症减少且结局改善,而另一些研究则报告无显著益处。
这项研究强调,与单独PC以及PC后再行CC相比,CC的结局更好,包括更低的死亡率和再入院率。联合方法相较于立即进行CC未显示出显著优势。需要进行更大规模的研究和标准化方案的进一步研究,以完善高风险AC患者的治疗策略。